Liver Cancer News
2024
March 2024
Innovative Yttrium-90 Radioisotopes Revolutionize Liver Cancer Treatment
ASCO GI Updates Provide Window Into Evolving HCC Treatment Paradigm
Liver Cancer Death Rates Have Stabilized in the US
Machine Learning Model Predicts Hepatocellular Carcinoma Risk in Patients With MASLD
Immune Evasion Tactics Of Liver Cancer Cells Revealed
First-Line Nivolumab/Ipilimumab Improves Survival in Hepatocellular Cancer
Podcast: Systemic Therapy for Advanced Hepatocellular Carcinoma Guideline Update
Immune Evasion Tactics Of Liver Cancer Cells Revealed
Georgia Hospital Is The First And Only In State To Offer Non-Invasive Liver Cancer Treatment
Maternal Obesity Linked To Liver Cancer Risk In Offspring
A Pioneering Way To Target The Culprit Behind A Deadly Liver Cancer
Study Finds Increasing Hepatocellular Carcinoma Incidence, Mortality in the US
Video: Cancer Conversation Liver Cancer
Possible Tumor Marker Found For The Development Of Hepatocellular Carcinoma
Rising Alcohol-Related Liver Cancer Prompts New Prediction Tool
February 2024
UC Davis Health Team Uses AI To Predict Risk Of Liver Cancer
Evolving Treatments in Hepatocellular Carcinoma: Updates from ASCO GI 2024
Old Vaccine Potentially Treats Liver Cancer
Hepatocellular Carcinoma Incidence And Mortality In The US By Sex, Age, And Race
Immune-Onc Collaborates with Roche for Liver Cancer Treatment Trial
TB Vaccine Shrinks Liver Cancer Tumors In Mice
AASLD Guidance on Liver Cancer Management
Liver Cancer: A Promising Avenue for More Effective Immunotherapies
Achieving SVR May Not Reduce Risk of HCC in Patients with HCV
Evidence-Based Nursing Achieves Better Postsurgical Outcomes in Liver Cancer
Blood Biomarkers in TGF-β Pathway Identify Hidden Liver Cancer Risk
Study Suggests The Possibility Of Combination Therapy Of SORA and FGF21 In Hepatocellular Carcinoma
Liver Cancer Impact In Mississippi Among Largest In US
FDA Fast Tracks BST02 for Liver Cancer
Diabetes And Liver Cancer — Stanford Medicine Study Suggests New Screening Guidelines
January 2024
Postoperative IMRT Improves RFS in Hepatocellular Carcinoma
Adding Immunotherapy to Local Treatment Delays Liver Cancer Progression
Oncofetal Ecosystems Linked To Recurrence And Immunotherapy Response In Liver Cancer
Video: Hope for Patients with Hepatocellular Carcinoma
What Patients With Liver Cancer Need to Know About Hepatitis B and C
AstraZeneca's (AZN) Imfinzi Combo Meets Liver Cancer Study Goal
Poor Liver Function Can Cause Side Effects, Drug Discontinuation in HCC
Pembrolizumab Combo Improves PFS/OS in Hepatocellular Carcinoma
Lenvatinib Combo Yields Safety, Disease Control in Hepatocellular Carcinoma
Hepatitis Treatments Underutilized Among ‘Sickest’ With Liver Cancer
Regorafenib Discontinuation More Likely With Poor Liver Function in Liver Cancer
Dr. Kim on Ongoing and Planned Research in HCC at Moffitt Cancer Center
Patient Adherence To Ultrasound Liver Cancer Surveillance Recs Is Low
Carsgen Therapeutics Cleared to Study Cell Therapy in Certain Liver Cancer Patients in China
The Search Continues for Viable Biomarkers in Hepatocellular Carcinoma
Dr. Kim on Selecting Between Frontline Immunotherapy-Based Regimens in HCC
Black People With Liver Cancer Are Less Likely To Receive Liver Transplants
Analysis Shows Increases in HCV-Related Liver Cancer, Mortality
New Technique Uses Microscopic Bubbles to Blast Cancer With Help From GI Research Foundation
New Discoveries and Potential Therapies for Liver Cancer: A Comprehensive Look
Dr. Kim on a Case Study of a Patient With HCC
Mailed Outreach Doubles Hepatocellular Carcinoma (HCC) Surveillance Imaging Uptake
SERS Used to Detect Early-Stage Liver Cancer
Silent Enemy: Alcohol And Liver Cancer
Future Directions in the Management of Hepatocellular Carcinoma
AI Offers Promise For Accurate Liver Cancer Diagnosis
For past liver cancer news, please visit our Liver Cancer News Archives.